Healthcare & Life Sciences
Helus Pharma
Canadacybin.com/
Helus Pharma is a Healthcare & Life Sciences startup based in Canada, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Helus Pharma
Helus Pharma is a company headquartered in Canada. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Helus Pharma develops novel serotonergic agonist therapies aimed at treating neuropsychiatric disorders such as anxiety by promoting neuroplasticity through next-generation drug formulations currently in clinical trials.
Explore Helus Pharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.